UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057733
Receipt number R000065929
Scientific Title A study on improving the uptake rate of esophagogastroduodenoscopy based on gastric cancer risk stratification by mailed examination
Date of disclosure of the study information 2025/04/28
Last modified on 2026/04/28 16:53:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on improving the uptake rate of esophagogastroduodenoscopy based on gastric cancer risk stratification by mailed examination

Acronym

A study on improving the uptake rate of esophagogastroduodenoscopy based on gastric cancer risk stratification by mailed examination

Scientific Title

A study on improving the uptake rate of esophagogastroduodenoscopy based on gastric cancer risk stratification by mailed examination

Scientific Title:Acronym

A study on improving the uptake rate of esophagogastroduodenoscopy based on gastric cancer risk stratification by mailed examination

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Medicine in general Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Provide gastric cancer risk stratification tests (ABC screening) that can be performed at home to those who have not yet undergone health checkup, and examine whether recommendations for secondary screening based on the results will lead to esophagogastroduodenoscopy examinations.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in behavior change stages by transtheoretical model (TTM)

Key secondary outcomes

Statistical analysis of gastric disease and patient background information for those who underwent endoscopy after explanation of ABC screening results


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Gastric cancer risk stratification test [ABC screening]

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Those who are 18 years of age or older at the time of obtaining consent
(2) Those who have agreed to participate in this study
(3) Those who have not undergone cancer screening or have not undergone endoscopy for more than 1 year
(4) Those who have requested to have the findings of ABC screening and recommendation for endoscopy through the telemedicine consultation
(5) Those who can undergo endoscopy at Fukushima Medical University Aizu Medical Center in principle when a full examination is required in this study

Key exclusion criteria

(1) Pregnant women
(2) Those with drug dependence or psychiatric disorders
(3) Those with stomach or other digestive system symptoms
(4) Patients under treatment for gastric diseases (gastric ulcer, duodenal ulcer, reflux esophagitis, etc.)
(5) Those who have had their stomach removed
(6) Those with renal failure
(7) Patients who have undergone eradication treatment for Helicobacter pylori
(8) Those who are participating in other clinical trials

Target sample size

42


Research contact person

Name of lead principal investigator

1st name Tadayuki
Middle name
Last name Takagi

Organization

Aizu Medical Center, Fukushima Medical University

Division name

Department of Gastroenterology

Zip code

969-3492

Address

21-2 Yazawa Aza Maeda, Kawahigashi-machi, Aizuwakamatu-city, Fukushima, Japan

TEL

0242-75-2100

Email

daccho@fmu.ac.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name Yatabe

Organization

Fukushima Medical University

Division name

Department of Digital Health Services Research

Zip code

960-1295

Address

1 Hikariga-oka, Fukushima City, JAPAN

TEL

024-547-1206

Homepage URL


Email

jyatabe@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Olympus Medical Systems co. ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Fukushima Medical University

Address

1 Hikariga-oka, Fukushima City, JAPAN

Tel

024-547-1825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 12 Month 02 Day

Date of IRB

2025 Year 02 Month 25 Day

Anticipated trial start date

2025 Year 05 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 28 Day

Last modified on

2026 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065929